Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2012
05/16/2012EP2452940A1 Azabicyclo compound and salt thereof
05/16/2012EP2452681A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof
05/16/2012EP2451813A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
05/16/2012EP2451810A1 Continuous flow process for the preparation of sulphoxide compounds
05/16/2012EP2451783A2 Lonidamine analogues for fertility management
05/16/2012EP2451285A1 Platelet-activating factor receptor antagonists
05/16/2012EP2451281A1 Tetrahydronapthyridine orexin receptor antagonists
05/16/2012EP2144902B1 [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
05/16/2012EP1851199B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/16/2012CN102459268A Diazahomoadamantane derivatives and methods of use thereof
05/16/2012CN102459267A Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
05/16/2012CN102459266A 3, 3'-螺二氢吲哚酮衍生物和它们用于癌症的用途 Uses 3, 3'-spiro-indolinone derivatives and their use for cancer
05/16/2012CN102459265A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459264A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459263A 取代的四氢β-咔啉的制备工艺 Preparation of substituted tetrahydro-β- carboline
05/16/2012CN102459262A 抑制raf蛋白激酶的吡咯并[2，3.b]吡啶 Inhibition of raf protein kinase pyrrolo [2,3.b] pyridine
05/16/2012CN102459261A 用于治疗变性和炎性疾病的新化合物 The new compounds for treating degenerative and inflammatory diseases for
05/16/2012CN102459260A 1H-吡唑并[4，3-c]异喹啉衍生物、其制备方法及其治疗用途 1H- pyrazolo [4,3-c] isoquinoline derivatives, their preparation and their therapeutic use
05/16/2012CN102459259A 吡唑并吡啶类 Pyrazolopyridines class
05/16/2012CN102459258A Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
05/16/2012CN102459257A 通过结晶优化活性药物成分的粒径的方法 Optimization of the particle size by crystallisation method the active pharmaceutical ingredient
05/16/2012CN102459249A 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxazepine cycloheptatriene and their use and manufacturing method
05/16/2012CN102459248A 作为PI3K/mTOR抑制剂的苯并氧杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxepin-triene and their method of use and manufacture
05/16/2012CN102459242A Phenoxymethyl heterocyclic compounds
05/16/2012CN102459225A Ccr2的4-氮杂环丁烷基-1-杂芳基-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroaryl - cyclohexane antagonist
05/16/2012CN102459193A 抗癌化合物和含有该化合物的药物组合物 Anti-cancer compounds and pharmaceutical compositions containing the compound
05/16/2012CN102459183A Inhibitors of human immunodeficiency virus replication
05/16/2012CN102459172A 四环化合物 Tetracyclic compounds
05/16/2012CN102458580A 作为mek抑制剂的杂环化合物 As a heterocyclic compound mek inhibitor
05/16/2012CN102458402A Nicotinamide compounds useful as kinase modulators
05/16/2012CN102453030A Matrine extraction technology
05/16/2012CN102453029A Novel crystal of paliperidone and preparation method thereof
05/16/2012CN102452989A Aniline substituted quinazoline derivative
05/16/2012CN101712680B Green method for synthesizing pyrido [1,2-a] pyrimidine-4-keone derivant
05/16/2012CN101253164B Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
05/15/2012USRE43390 Pleuromutilin derivatives as antimicrobials
05/15/2012US8178677 Hydroxyalkyl substituted imidazoquinolines
05/15/2012US8178668 2-aminopyridine kinase inhibitors
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
05/15/2012US8178559 Organic compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178554 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
05/15/2012US8178553 Compounds for the treatment of inflammatory disorders
05/15/2012US8178552 7-Azaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase
05/15/2012US8178545 Dual small molecule inhibitors of cancer and angiogenesis
05/15/2012US8178131 Pyrrolopyridines as kinase inhibitors
05/15/2012CA2518620C 2,4,6-phenyl substituted cyclic ketoenols
05/15/2012CA2470863C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/15/2012CA2430978C Vla-4 inhibitors
05/10/2012WO2012061428A2 Nicotinamides as jak kinase modulators
05/10/2012WO2012061342A2 Substituted benzo-imidazo-pyrido-diazepine compounds
05/10/2012WO2012060590A2 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
05/10/2012WO2012059549A1 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof
05/10/2012WO2012059548A1 Benzyl-substituted carbamates and use thereof
05/10/2012WO2012059232A1 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof
05/10/2012WO2012059172A1 1h-pyrrolo[2,3-b]pyridine derivatives
05/10/2012WO2012058763A1 Synthetic lethality in cancer
05/10/2012WO2012040048A3 Triazolopyrazinones as p2x7 receptor antagonists
05/10/2012WO2012019430A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012WO2012019426A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012WO2012018932A3 Compounds and compositions for mitigating tissue damage and lethality
05/10/2012WO2011031818A3 Histamine h3 inverse agonists and antagonists and methods of use thereof
05/10/2012US20120116087 Crystals of pyrroloquinolinequinone sodium salts
05/10/2012US20120116084 N-type organic semiconductors including at least two 2-dicyanomethylene-3-cyano-2,5-dihydrofuran groups
05/10/2012US20120116080 Process for the stereoselective preparation of bicyclic heterocycles
05/10/2012US20120116072 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115900 Substituted naphthyridine derivatives and their medical use
05/10/2012US20120115899 Naphthyridin-2 (1 h)-one compounds useful as antibacterials
05/10/2012US20120115898 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
05/10/2012US20120115883 Pyrimidine derivatives which are antagonists of the vitronectin receptor
05/10/2012US20120115870 Control of intraocular pressure using alk5 modulation agents
05/10/2012US20120115851 Compound inhibiting in vivo phosphorus transport and medicine containing the same
05/10/2012US20120115848 Inhibitors of Polo-Like Kinase
05/10/2012US20120115844 Novel triazole compounds i
05/10/2012US20120115820 Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
05/10/2012US20120114639 Compositions and methods for inhibiting viral and/or bacterial infections
05/10/2012US20120114624 Nematocidal sulfonamides
05/10/2012DE102010050558A1 1H-Pyrrolo[2,3-b]pyridinderivate 1H-pyrrolo [2,3-b] pyridine
05/10/2012DE102010043380A1 Benzyl-substituierte Carbamate und ihre Verwendung Benzyl-substituted carbamates and their use
05/10/2012DE102010043379A1 Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung Substituted 6-fluoro-1H-pyrazolo [4,3-b] pyridines and their use
05/10/2012CA2816929A1 Synthetic lethality in cancer
05/10/2012CA2816896A1 1h-pyrrolo[2,3-b]pyridine derivatives
05/10/2012CA2816671A1 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof
05/10/2012CA2816639A1 Benzyl-substituted carbamates and use thereof
05/10/2012CA2814357A1 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
05/09/2012EP2450358A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase
05/09/2012EP2450351A1 Lactam compounds and their use as pharmaceuticals
05/09/2012EP2448937A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/09/2012EP2448920A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/09/2012EP2448585A1 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
05/09/2012EP2280953B1 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
05/09/2012CN1626527B Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative
05/09/2012CN102448962A Heterocyclic urea derivatives and methods of use thereof
05/09/2012CN102448961A Dihydro) imidazoiso (5, 1-A) quinolines as fsh receptor agonists for the treatment of fertility disorders
05/09/2012CN102448960A Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-carboxylic acid amides
05/09/2012CN102448959A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/09/2012CN102448946A Materials for organic electroluminescent devices
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 646